Xu-Dong Qu

Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations

Xiao‐Dong Zhu, Cheng Huang, Ying‐Hao Shen et al. · Liver Cancer · 2021 · 237 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma

Bo Zhou, Zhiping Yan, Rong Liu et al. · Radiology · 2016 · 97 citations

Medicine, Oncology, Pharmacology +12

The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma

Xu-Dong Qu, Chengshi Chen, Jianhua Wang et al. · BMC Cancer · 2012 · 86 citations · Full text

Medicine, Oncology, Surgery +12

Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma

Xiao‐Dong Zhu, Cheng Huang, Ying‐Hao Shen et al. · Annals of Surgical Oncology · 2022 · 72 citations · Full text

Medicine, Oncology, Surgery +16

Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study

Wei‐Feng Qu, Zhen‐Bin Ding, Xu-Dong Qu et al. · BJS Open · 2022 · 58 citations · Full text

Medicine, Oncology, Surgery +17